Infectious Disease and Microbiology - Traveler’s diarrhea

Basics

Description

Traveler’s diarrhea is the most frequent illness encountered by people traveling internationally. It usually represents an acute gastrointestinal infection acquired after ingestion of food or water contaminated by fecal organisms. The likelihood of developing illness depends heavily on the travel destination, local sanitation, food preparation and storage practices, and the traveler’s own dietary and hygiene habits.

Most episodes are mild and resolve spontaneously. However, symptoms may significantly interfere with travel plans, and substantial fluid loss can occasionally produce clinically important dehydration.

⸻

Epidemiology

Incidence

Approximately 20–50% of international travelers may develop diarrhea during travel. Men and women appear to have similar attack rates, but the overall risk varies considerably according to destination.

Historically, the highest-risk regions have included Latin America, Africa, much of Asia, and the Middle East, where attack rates may exceed 20% and sometimes 50%. Intermediate-risk areas have included parts of Southern Europe, Israel, and selected Caribbean islands. Lower-risk destinations generally include the United States, Canada, Northern Europe, Australia, New Zealand, Japan, and much of the Caribbean.

⸻

Risk factors

Factors that increase the likelihood of traveler’s diarrhea include travel to regions with poor sanitation, failure to follow food and water precautions, immunocompromised status, inflammatory bowel disease, and reduced gastric acidity, particularly in people taking proton-pump inhibitors.

Students, backpackers, adventure travelers, and individuals with repeated previous episodes may also be at increased risk. Pregnancy may increase susceptibility because physiologic changes can alter gastric acidity and gastrointestinal function.

⸻

Etiology

Most cases of traveler’s diarrhea are infectious, with bacteria responsible for the majority of episodes.

Bacterial causes

Bacteria account for roughly 80–90% of identified cases. The classic and important pathogen is enterotoxigenic Escherichia coli (ETEC). Enteroaggregative E. coli is also increasingly recognized.

Other bacterial causes include Campylobacter, nontyphoidal Salmonella, Shigella, Aeromonas, Plesiomonas shigelloides, and non-cholera Vibrio species.

Viral causes

Viruses account for a smaller proportion of disease. Important agents include norovirus and rotavirus.

Norovirus is particularly associated with outbreaks in cruise ships, camps, and other closed or semi-closed environments. Prominent vomiting is a useful clinical clue.

Parasitic causes

Protozoal infections become increasingly important in travelers with prolonged symptoms or long-duration travel. Important organisms include Giardia duodenalis, Entamoeba histolytica, Cryptosporidium, Cyclospora cayetanensis, Cystoisospora belli, and Balantidium coli.

Giardia is especially associated with contaminated food or water and wilderness exposure. E. histolytica may be acquired from contaminated food, water, or vegetables. Cryptosporidium can be transmitted through contaminated water or animal exposure, while Cyclospora is commonly linked to contaminated food or water.

⸻

Incubation period

The incubation period can help suggest the likely category of pathogen.

Cause

Typical incubation

Bacterial infection

6–48 hours

Viral infection

6–48 hours

Protozoal infection

Usually 1–2 weeks

A rapid onset shortly after exposure favors a bacterial or viral cause, whereas delayed onset with persistent diarrhea should raise suspicion for protozoal infection.

⸻

Clinical presentation

Classic traveler’s diarrhea

Traditionally, classic disease has been defined as three or more unformed stools within 24 hours together with at least one additional symptom such as nausea, vomiting, abdominal pain, cramps, fever, or blood in the stool.

Moderate disease

Moderate illness has traditionally included one or two loose stools accompanied by additional enteric symptoms, or multiple unformed stools with enough discomfort to interfere with usual activities.

Mild disease

Mild illness typically consists of only one or two loose stools with little or no associated systemic disturbance.

In contemporary practice, severity is increasingly judged by how much the illness interferes with planned activities, rather than by stool number alone.

⸻

Clinical patterns according to cause

Bacterial diarrhea

Bacterial illness usually begins abruptly. Manifestations range from mild urgency, cramping, and watery stools to severe abdominal pain, fever, vomiting, and bloody diarrhea.

Without treatment, bacterial traveler’s diarrhea commonly lasts around 3–5 days.

Viral diarrhea

Viral gastroenteritis may closely resemble bacterial disease. Norovirus often produces prominent vomiting and usually resolves within approximately 2–3 days.

Protozoal diarrhea

Protozoal disease tends to develop more gradually and often produces fewer but persistent loose stools. Patients may have approximately two to five loose stools daily, with symptoms continuing for weeks or even months if untreated.

⸻

Physical examination

Examination may reveal loose or watery stools, abdominal tenderness, and evidence of dehydration. Bloody stool occurs in a minority of cases and should increase concern for an invasive enteric pathogen.

Important signs of dehydration include tachycardia, orthostatic hypotension, dry mucous membranes, reduced urine output, poor skin turgor, and altered mental status in severe cases.

Young children, older adults, pregnant patients, and medically vulnerable individuals are particularly susceptible to complications from fluid loss.

⸻

Diagnosis

Traveler’s diarrhea is usually diagnosed clinically from the combination of recent travel and compatible gastrointestinal symptoms. Routine laboratory testing is unnecessary in most uncomplicated, short-lived episodes.

⸻

Diagnostic testing

Stool studies

Microbiologic stool testing should be considered when there is high fever, bloody diarrhea, severe illness, features of colitis, immunocompromise, failure of empiric treatment, or prolonged symptoms.

Stool culture is particularly appropriate in patients with fever and inflammatory or bloody diarrhea.

Persistent diarrhea

Diarrhea lasting longer than approximately 10–14 days should prompt evaluation for protozoal infection.

Important organisms include:

• Giardia duodenalis
• Entamoeba histolytica
• Cryptosporidium
• Cyclospora cayetanensis

A useful clinical rule is:

Traveler with diarrhea lasting more than 2 weeks → think protozoa.

⸻

Differential diagnosis

Not every gastrointestinal illness that develops during travel is infectious traveler’s diarrhea. Other possibilities include food poisoning caused by preformed toxins, shellfish poisoning, scombroid poisoning, and ciguatera poisoning.

Depending on the clinical presentation, other infectious diarrheal illnesses, inflammatory bowel disease, and noninfectious gastrointestinal disorders may also need to be considered.

⸻

General prevention

The major preventive goal is to avoid ingestion of fecally contaminated food and water.

Travelers should avoid unsafe tap water, including its use for brushing teeth when water quality is uncertain. Ice should be avoided unless made from purified water. Unpasteurized dairy products, raw or undercooked meat or seafood, unpeeled raw fruits, inadequately washed vegetables, raw leafy vegetables, and food from vendors with questionable hygiene should also be avoided.

A practical rule is:

Boil it, cook it, peel it—or leave it.

⸻

Water safety

Boiling

Boiling remains one of the most dependable simple methods of making water microbiologically safer.

Chlorination and iodination

Chemical disinfection can reduce many infectious risks, but it is less reliable against organisms such as Cryptosporidium.

Bottled water

Commercial bottled water is generally considered safer when the original cap and seal remain intact.

⸻

Hand hygiene

Travelers should wash their hands with soap and safe water whenever possible, especially before eating or handling food. When soap and water are unavailable, an alcohol-based hand sanitizer containing at least 60% alcohol can be used.

Good hand hygiene reduces both foodborne transmission and direct person-to-person spread.

⸻

Chemoprophylaxis

Antibiotic prophylaxis

Although prophylactic antibiotics can decrease the frequency of traveler’s diarrhea, routine use is not recommended for most travelers because of adverse effects, alteration of normal intestinal flora, and increasing antimicrobial resistance.

Preventive antibiotics may occasionally be considered for selected high-risk individuals when even a brief diarrheal illness could have serious medical, occupational, or logistical consequences.

Historically used agents have included rifaximin and fluoroquinolones, but contemporary decisions should take current resistance patterns into account.

Bismuth subsalicylate

Bismuth subsalicylate can reduce the incidence of traveler’s diarrhea and is one of the better studied non-antibiotic preventive strategies.

A historically used regimen is two 262-mg tablets or 60 mL four times daily for up to about 3 weeks.

It should be avoided or used cautiously in patients taking anticoagulants or other salicylates and in those with contraindications to salicylate therapy. It may also interfere with doxycycline absorption.

Probiotics

Evidence supporting probiotics for prevention remains inconsistent. Preparations studied include Lactobacillus species and Saccharomyces boulardii.

They should not replace food, water, and hygiene precautions.

⸻

Treatment

Rehydration is the priority

The most important treatment for traveler’s diarrhea is replacement of fluids and electrolytes.

Most infections are self-limited, and the greatest immediate danger—especially in vulnerable patients—is dehydration.

Oral rehydration solution (ORS) is particularly useful for infants, children, older adults, and patients with substantial fluid loss. Severe dehydration or inability to tolerate oral fluids may require intravenous therapy.

⸻

Antibiotic treatment

Antibiotics can shorten the duration of moderate-to-severe bacterial disease but are unnecessary for every mild episode.

Choice of therapy depends on the travel destination, illness severity, presence of fever or dysentery, local resistance patterns, pregnancy status, age, and underlying medical conditions.

Azithromycin

Azithromycin is especially useful when there is febrile diarrhea, dysentery, or travel to regions with high rates of fluoroquinolone-resistant Campylobacter, particularly parts of South and Southeast Asia.

A commonly cited regimen is azithromycin 1 g orally as a single dose.

It is also an important option for children and pregnant patients when antimicrobial treatment is indicated.

Fluoroquinolones

Ciprofloxacin was historically a major treatment option. A classic regimen is ciprofloxacin 500 mg orally twice daily for 3 days.

However, fluoroquinolones are less universally useful today because resistance has increased, particularly among Campylobacter and some other enteric organisms. Safety concerns related to the drug class must also be considered.

Rifaximin

Rifaximin is a poorly absorbed antibiotic that may be used for afebrile, noninvasive, nondysenteric traveler’s diarrhea.

A commonly cited regimen is 200 mg orally twice daily for 3 days.

It should not be relied on when there is fever, bloody diarrhea, or concern for an invasive bacterial infection.

A useful distinction is:

Watery + afebrile → rifaximin may be appropriate.

Fever or blood → think invasive disease and choose another approach.

⸻

Symptomatic therapy

Loperamide

Loperamide decreases intestinal motility and can provide rapid symptomatic relief, particularly when the traveler needs short-term control of diarrhea.

It may also be combined with an appropriate antibiotic in selected moderate-to-severe cases.

Loperamide should generally not be used alone when there is bloody diarrhea, high fever, or suspected invasive bacterial colitis. Extra caution is required in young children.

Bismuth subsalicylate

Bismuth subsalicylate may also reduce diarrhea and gastrointestinal discomfort. A traditional regimen is two 262-mg tablets or 60 mL up to four times daily.

It should be avoided when salicylates are contraindicated.

⸻

Protozoal infections

Persistent post-travel diarrhea requires a different diagnostic and therapeutic approach from ordinary acute bacterial traveler’s diarrhea.

Giardiasis

Giardia should be suspected when persistent diarrhea is accompanied by bloating, flatulence, malabsorption, greasy or foul-smelling stools, or a history of contaminated water exposure.

A traditional treatment regimen is metronidazole 250 mg orally three times daily for 5 days.

Amebiasis

Invasive Entamoeba histolytica infection requires therapy against both invasive trophozoites and organisms remaining within the intestinal lumen.

A classic regimen is metronidazole 500–750 mg orally three times daily for 10 days, followed by a luminal agent such as paromomycin or iodoquinol.

A key principle is:

Metronidazole alone is not adequate treatment for invasive amebiasis. A luminal amebicide must follow.

⸻

Pregnancy considerations

Pregnant travelers require careful attention to dehydration and medication safety.

Azithromycin may be used when antibiotic treatment is required. Fluoroquinolones are generally avoided when suitable alternatives are available. Bismuth subsalicylate is usually avoided, and the safety of rifaximin in pregnancy has not been sufficiently established for routine use.

Loperamide may sometimes be considered depending on the clinical circumstances. Medication choices should be individualized.

⸻

Pediatric considerations

Infants and young children can become dehydrated quickly. The priority is oral rehydration and close monitoring.

Medical evaluation is especially important when a child has persistent vomiting, inability to drink, markedly reduced urine output, lethargy, high fever, bloody diarrhea, or other signs of significant dehydration.

⸻

Diet during recovery

Normal feeding can usually be resumed early as tolerated. Prolonged fasting is unnecessary.

Temporary reduction of alcohol, coffee or caffeine, carbonated drinks, and dairy products may be helpful if these worsen symptoms.

The main priority remains adequate fluid, electrolyte, and nutritional intake.

⸻

Prognosis

Most cases of traveler’s diarrhea resolve without lasting consequences.

Typical untreated durations are approximately:

• Viral illness: 2–3 days
• Bacterial illness: 3–5 days
• Protozoal illness: potentially weeks to months

The most important immediate threat is dehydration, especially in young children, older adults, pregnant patients, and people with significant underlying disease.

⸻

Complications

Dehydration

This is the most important acute complication. Severe volume loss can cause electrolyte abnormalities, hypotension, acute kidney injury, and shock.

Reactive arthritis

Reactive arthritis can develop after infections caused by organisms such as Campylobacter, Salmonella, and Shigella.

Guillain–Barré syndrome

Campylobacter jejuni infection is a well-known infectious trigger for Guillain–Barré syndrome.

Postinfectious irritable bowel syndrome

Some patients develop persistent gastrointestinal symptoms even after the original infection has cleared. Manifestations may include abdominal discomfort, altered bowel frequency, diarrhea, constipation, and bloating.

This condition is known as postinfectious irritable bowel syndrome.

⸻

High-yield approach to traveler’s diarrhea

Clinical pattern

Likely consideration

Acute watery diarrhea after travel

ETEC or another bacterial cause

Prominent vomiting during a cruise-ship or camp outbreak

Norovirus

Fever with bloody diarrhea

Invasive bacterial infection

South/Southeast Asia with inflammatory diarrhea

Resistant Campylobacter; azithromycin often useful

Diarrhea persisting >2 weeks

Protozoal infection

Persistent diarrhea with bloating or greasy stools

Giardia

Dysentery with appropriate exposure

E. histolytica

Weakness after Campylobacter infection

Guillain–Barré syndrome

Arthritis after bacterial diarrhea

Reactive arthritis

Chronic bowel symptoms after infection

Postinfectious IBS

⸻

Exam essentials

Most common illness affecting international travelers:

→ Traveler’s diarrhea

Major route of acquisition:

→ Fecally contaminated food or water

Most cases are caused by:

→ Bacteria

Classic major pathogen:

→ Enterotoxigenic Escherichia coli (ETEC)

Prominent vomiting suggests:

→ Norovirus

Persistent or delayed diarrhea suggests:

→ Protozoal infection

Most important treatment:

→ Fluid and electrolyte replacement

Common antimotility drug:

→ Loperamide

Avoid loperamide alone when there is:

→ Bloody diarrhea or high fever

Rifaximin is best suited for:

→ Afebrile, noninvasive, nondysenteric diarrhea

Important fluoroquinolone resistance problem:

→ Campylobacter, especially in South and Southeast Asia

Useful antibiotic for dysentery or resistant Campylobacter:

→ Azithromycin

Treatment principle for invasive amebiasis:

→ Tissue-active therapy followed by a luminal amebicide

Diarrhea lasting >10–14 days:

→ Investigate for protozoa

Important Campylobacter complication:

→ Guillain–Barré syndrome

Important long-term complication after traveler’s diarrhea:

→ Postinfectious irritable bowel syndrome